The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...
The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...
Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback